Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2003
10/29/2003CN1125807C Excitatory amino acid receptor modulators
10/29/2003CN1125647C Fumigation washing matter for treating anal diseases
10/29/2003CN1125632C Skin care rose water
10/29/2003CN1125595C Oral composition with cardiovascular health and senility delaying functions
10/28/2003US6639111 Bind on EP4 subtype receptor selectively and binds on the other subtype receptors weakly; side-effect reduction; autoimmune diseases; asthma; bone disorders; degenerative nerve diseases; sleeping disorders; anticoagulants
10/28/2003US6638980 Inhibitors of factor Xa
10/28/2003US6638969 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
10/28/2003US6638964 Sulfonamide-containing indole compounds
10/28/2003US6638953 Indole derivatives as 5-HT receptor antagonist
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638947 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/28/2003US6638945 Quinoline derivatives as inhibitors of MEK enzymes
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638936 Treatment of obesity in mammals, comprising administering to mammal in need of such treatment, treatment of obsessive compulsive disorder in mammals, comprising administering to a mammal treatment of depression in mammals
10/28/2003US6638934 2,3,4,4a,5,6-hexahydro-1H-pyrazino(1,2-a)quinoxaline derivatives; treating depression, schizophrenia; (5-hydroxytryptamine=5HT) 5HT2a antagonist or a 5HT2c agonist
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638923 Estra-1,3,5(10),16-tetraene derivatives
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003US6638916 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
10/28/2003US6638913 Concentrated injection and infusion solution for intravenous administration
10/28/2003US6638736 Gene expression inhibition; cancer and neurodegenerative disease diagnosis; molecular hybridization
10/28/2003US6638727 Intraductally administering an estrogen activity modulator
10/28/2003US6638530 N-(2-anilino)- and pyridino- substituents; mixed with polyoxyethylene glycol and surfactant, mineral acid salt of amino acid or propylene carbonate; absorbability; anticarcinogenic agents, immunosuppressants
10/28/2003US6638521 Oral liquid mucoadhesive compositions
10/28/2003CA2254521C New pyrrol derivatives, their method of preparation and pharmaceutical compositions containing these derivatives
10/28/2003CA2253796C Inhibition of matrix metalloproteases by acetylene containing compounds
10/28/2003CA2252701C Halo-substituted protein kinase c inhibitors
10/28/2003CA2249448C Egg anti-inflammatory composition, method of isolation and use
10/28/2003CA2101179C Phenylimidazolidine derivatives, their preparation and their use
10/28/2003CA2058020C Short peptides with insulin activity
10/28/2003CA2037116C Hexahydrobenz ¢cd! indoles
10/23/2003WO2003087841A2 An ephrin-b receptor protein involved in carcinoma
10/23/2003WO2003087818A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
10/23/2003WO2003087406A1 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases
10/23/2003WO2003087399A1 Nad)p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes
10/23/2003WO2003087383A1 Compositions for delivering enyzmes involved in amino acid metabolism using recombinant ademo-associated virus virons (raav virons), and method and use for treating aminoi acid metabolic disorders using such raav virons
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087368A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003WO2003087367A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003WO2003087364A1 Novel g protein-coupled receptor and its gene
10/23/2003WO2003087345A2 Stimulation of nerve cell regeneration
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087333A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087318A2 Truncated 24 kda basic fibroblast growth factor
10/23/2003WO2003087304A2 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003WO2003087298A2 Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087155A1 Novel protein and dna thereof
10/23/2003WO2003087144A2 Insecticide proteins from photorabdus luminescens
10/23/2003WO2003087139A2 Treatment of gastroparesis
10/23/2003WO2003087121A1 Branched polyamine steroid derivatives
10/23/2003WO2003087120A1 Estrone derivative and process for producing the same
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087105A1 INHIBITORS OF SERINE AND METALLO-ß-LACTAMASES
10/23/2003WO2003087104A1 Heterocyclic compounds
10/23/2003WO2003087103A1 Thienyl compounds
10/23/2003WO2003087102A1 Furyl compounds
10/23/2003WO2003087101A1 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles
10/23/2003WO2003087097A1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug
10/23/2003WO2003087096A1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
10/23/2003WO2003087095A1 Quinolinone derivatives
10/23/2003WO2003087092A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
10/23/2003WO2003087091A1 Novel crystal of quinoxalinedione derivative anhydride
10/23/2003WO2003087090A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003WO2003087089A1 Piperidine derivatives having ccr3 antagonism
10/23/2003WO2003087088A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087086A2 Substituted indoles
10/23/2003WO2003087085A1 Heterocyclic amide derivatives as cytokine inhibitors
10/23/2003WO2003087072A1 Therapeutic agent for endothelial disorder
10/23/2003WO2003087065A1 Inhibitors of glycinamide ribonucleotide transformylase
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087050A2 Novel perindopril salt and pharmaceutical compositions containing same
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003087026A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003WO2003086472A1 Drugs to be used in gene therapy for recessively transmitted genetic disease
10/23/2003WO2003086467A1 Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitor
10/23/2003WO2003086466A1 Novel thrombomodulin expression promoters
10/23/2003WO2003086465A1 Drugs for myopia correction surgery
10/23/2003WO2003086464A1 Preventives/remedies for hotflash
10/23/2003WO2003086459A1 Methods of treatement using ctla-4 antibodies
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086450A1 Active antiangiogenic therapy
10/23/2003WO2003086448A1 Use of c5a receptor antagonist in the treatment of fibrosis
10/23/2003WO2003086436A1 Enteric fat absorption inhibitors contaiing plant extract and foods containing the same
10/23/2003WO2003086421A1 External preparations for enhancing cell activity
10/23/2003WO2003086419A1 Antibiotic/benzoyl peroxide dispenser
10/23/2003WO2003086415A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation
10/23/2003WO2003086410A1 Pharmaceutical compositions comprising a 11-beta hydroxysteroid dehydrogenase inhibitor and a diuretic agent
10/23/2003WO2003086409A1 The use of devazepide as analgesic agent
10/23/2003WO2003086404A1 Fused quinoxaline derivatives as inhibitors of akt activity
10/23/2003WO2003086403A1 Inhibitors of akt activity
10/23/2003WO2003086400A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
10/23/2003WO2003086399A1 Medicaments containing steroids and a novel anticholinesterase drug
10/23/2003WO2003086397A1 Medicine for treating cancer
10/23/2003WO2003086396A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003WO2003086395A1 Tyrosine kinase inhibitors
1 ... 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 ... 1564